Brain Development: The impact of light during the night
Modern life exposes us to multiple sources of artificial light at times when we normally would experience darkness. You could, for example, be reading this article at night on the glowing screen of a computer or tablet. There is mounting evidence, however, that irregular 'light-at-night' can affect mood and brain function (Bedrosian and Nelson, 2017). The developing brain is particularly sensitive to night-time light (Logan and McClung, 2019), and this could result in changes that persist into adult life.
Now, in eLife, Shogo Haraguchi, Kazuyoshi Tsutsui and colleagues at Waseda University, Showa University School of Medicine and other institutes in Japan report that inappropriate light-at-night can have adverse long-term effects on the survival of nerve cells in the developing brain of chicks (Haraguchi et al., 2019). Chicks are an ideal model system for studying how light affects the developing brain because, like people, chickens are diurnal (i.e., they are active during the day and sleep at night).
Haraguchi et al. focused on a small gland located deep in the brain called the pineal gland, which regulates the sleep-wake cycle by producing and releasing a hormone known as melatonin (Borjigin et al., 2012). The pineal gland synthesizes melatonin in rhythmic cycles, releasing low levels during the day and high levels at night. However, the release of melatonin during the night can be suppressed by exposure to bright light. In addition to melatonin, the pineal gland also produces and releases various steroids, including a steroid called ALLO (short for allopregnanolone; Haraguchi et al., 2012).
Haraguchi et al. showed that when hatchling chicks were repeatedly exposed to 12 hours of light followed by 12 hours of darkness, ALLO expression in the pineal gland peaked four hours into the dark cycle (at hour 16 of the 24-hour cycle). However, when the chicks were exposed to constant light, ALLO levels remained low and the peak in expression during the dark cycle could no longer be detected. Notably, exposing chicks to just one hour of light during the night (14-15 hours into the cycle) was enough to abolish the peak in ALLO synthesis (Figure 1).
Next, Haraguchi et al. determined how changes in ALLO expression affected the development of Purkinje cells in the cerebellum: this region of the brain, which is located next to the pineal gland, is important for motor coordination and cognition (Koziol et al., 2014). They found that exposing chicks to constant light, or one hour of aberrant light per night, the week after hatching caused an increase in the death of Purkinje cells: moreover, these losses were observed predominantly in the part of the cerebellum closest to the pineal gland and persisted into young adulthood (Figure 1). Further experiments showed that the Purkinje cells did not die when chicks exposed to one hour of light per night were injected with a daily dose of ALLO. This suggests that Purkinje cells in the developing brain need ALLO in order to survive.
To determine the underlying mechanisms that cause Purkinje cell death, Haraguchi et al. carried out a series of experiments in which they down-regulated the expression of specific proteins in the egg. This revealed that ALLO acted via a receptor on the cell membrane known as mPRα, and this led to daily peaks in expression of a neuroprotective hormone called PACAP during the dark phase of the cycle. Epigenetic regulation of the gene that controls PACAP during development caused expression levels of this hormone to vary between chicks. Chicks exposed to night-time light in the second week after hatching also experienced Purkinje cell death. However, the damage caused by this later exposure could be rescued by PACAP, but not by the addition of ALLO. This suggests that the actions of light-at-night in the brain may involve different pathways at different stages of development.
Purkinje cell death is observed in several neurological disorders, including autism (Jayabal and Watt, 2019), and the pattern of Purkinje cell death following light-at-night exposure during development is similar to the patterns of cell death observed in several ataxia disorders that affect motor coordination (Langmade et al., 2006; Larivière et al., 2015). Since disrupted sleep is a common component of many ataxia disorders (Huebra et al., 2019), this study suggests that cell survival in neurogenerative diseases may be linked to changes in neurosteroid production caused by interrupted sleep.
Caution, however, must be taken when translating these results to humans, since the stages of brain development in chicks are not directly comparable to humans. Nonetheless, this study raises important concerns about how light exposure at night affects the developing brain. In addition to helping you get a good night’s sleep, turning off screens and shutting blinds at night may help maintain the production of a neurosteroid that cells in the developing brain need to survive.
References
-
Timing of light exposure affects mood and brain circuitsTranslational Psychiatry 7:e1017.https://doi.org/10.1038/tp.2016.262
-
Circadian regulation of pineal gland rhythmicityMolecular and Cellular Endocrinology 349:13–19.https://doi.org/10.1016/j.mce.2011.07.009
-
Sleep disorders in hereditary ataxiasCurrent Neurology and Neuroscience Reports 19:59.https://doi.org/10.1007/s11910-019-0968-1
-
BookDevelopment of Physiological Activity in the CerebellumIn: Manto M. G. D, Schmahmann J, Koibuchi N, Sillitoe R, editors. Handbook of the Cerebellum and Cerebellar Disorders. Springer. pp. 1–30.https://doi.org/10.1007/978-3-319-97911-3_111-2
-
Rhythms of life: circadian disruption and brain disorders across the lifespanNature Reviews Neuroscience 20:49–65.https://doi.org/10.1038/s41583-018-0088-y
Article and author information
Author details
Publication history
Copyright
© 2019, Leung et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 3,314
- views
-
- 177
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
The concept that dimeric protein complexes in synapses can sequentially replace their subunits has been a cornerstone of Francis Crick’s 1984 hypothesis, explaining how long-term memories could be maintained in the face of short protein lifetimes. However, it is unknown whether the subunits of protein complexes that mediate memory are sequentially replaced in the brain and if this process is linked to protein lifetime. We address these issues by focusing on supercomplexes assembled by the abundant postsynaptic scaffolding protein PSD95, which plays a crucial role in memory. We used single-molecule detection, super-resolution microscopy and MINFLUX to probe the molecular composition of PSD95 supercomplexes in mice carrying genetically encoded HaloTags, eGFP, and mEoS2. We found a population of PSD95-containing supercomplexes comprised of two copies of PSD95, with a dominant 12.7 nm separation. Time-stamping of PSD95 subunits in vivo revealed that each PSD95 subunit was sequentially replaced over days and weeks. Comparison of brain regions showed subunit replacement was slowest in the cortex, where PSD95 protein lifetime is longest. Our findings reveal that protein supercomplexes within the postsynaptic density can be maintained by gradual replacement of individual subunits providing a mechanism for stable maintenance of their organization. Moreover, we extend Crick’s model by suggesting that synapses with slow subunit replacement of protein supercomplexes and long-protein lifetimes are specialized for long-term memory storage and that these synapses are highly enriched in superficial layers of the cortex where long-term memories are stored.
-
- Neuroscience
Motivation depends on dopamine, but might be modulated by acetylcholine which influences dopamine release in the striatum, and amplifies motivation in animal studies. A corresponding effect in humans would be important clinically, since anticholinergic drugs are frequently used in Parkinson’s disease, a condition that can also disrupt motivation. Reward and dopamine make us more ready to respond, as indexed by reaction times (RT), and move faster, sometimes termed vigour. These effects may be controlled by preparatory processes that can be tracked using electroencephalography (EEG). We measured vigour in a placebo-controlled, double-blinded study of trihexyphenidyl (THP), a muscarinic antagonist, with an incentivised eye movement task and EEG. Participants responded faster and with greater vigour when incentives were high, but THP blunted these motivational effects, suggesting that muscarinic receptors facilitate invigoration by reward. Preparatory EEG build-up (contingent negative variation [CNV]) was strengthened by high incentives and by muscarinic blockade, although THP reduced the incentive effect. The amplitude of preparatory activity predicted both vigour and RT, although over distinct scalp regions; frontal activity predicted vigour, whereas a larger, earlier, central component predicted RT. The incentivisation of RT was partly mediated by the CNV, though vigour was not. Moreover, the CNV mediated the drug’s effect on dampening incentives, suggesting that muscarinic receptors underlie the motivational influence on this preparatory activity. Taken together, these findings show that a muscarinic blocker impairs motivated action in healthy people, and that medial frontal preparatory neural activity mediates this for RT.